Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Assessment of Gut Microbiota in the Elderly With Sarcopenic Obesity: A Case-Control Study Publisher



Fs Hosseini Fatemeh SADAT ; A Behrouzi AVA ; E Shafaei EBRAHIM ; F Sharifi FARSHAD ; H Ejtahed Haniehsadat S
Authors

Source: Journal of Diabetes and Metabolic Disorders Published:2025


Abstract

Objectives: Sarcopenic obesity is a multifactorial disorder commonly found in elderly individuals. One contributing factor is gut microbiota dysbiosis. This study compared the abundance of certain bacteria in elderly individuals with obesity and sarcopenic obesity. Methods: The study included 50 elderly individuals over 65 with a body mass index (BMI) of over 30 kg/m², both sexes. Participants were divided into two groups, each with 25 individuals, based on the diagnosis of sarcopenia using the EWGSOP2 criteria. Individuals with underlying diseases, those using antibiotics, and those with a history of gastrointestinal surgery were excluded. Stool samples were stored at -80 °C, and DNA was extracted using standard kits. Bacterial DNA sample quality was assessed using a Nanodrop device. Bacterial frequency was measured using qPCR. The log cfu for each bacteria was calculated and compared in both groups using an independent t-test. Spearman measured the correlation between bacterial genera and physical performance in SPSS 26. Results: The case group had a significantly higher average age (70.96) than the control group (68.32). The average BMI was the same in both groups. The frequency of Escherichia (p-value = 0.046) and Bifidobacterium (p-value = 0.017) was significantly higher in the case group. There was no significant difference in the frequency of Lactobacillus and Akkermansia. Conclusion: The study uncovered substantial differences in gut microbiota composition between elderly individuals experiencing sarcopenic obesity and those with obesity alone. The findings suggest that dysbiosis, characterized by an excessive presence of Bifidobacterium, Escherichia, and Akkermansia, may be associated with sarcopenic obesity. © 2025 Elsevier B.V., All rights reserved.
Other Related Docs
12. The Role of Intestinal Microbiota in Cognitive Disorders, Journal of Mazandaran University of Medical Sciences (2021)
15. Sarcopenia Disease in Iran: An Overview, Journal of Diabetes and Metabolic Disorders (2019)
16. Diet-Microbiota Interactions: A New Approach to Personalized Nutrition, Journal of Mazandaran University of Medical Sciences (2021)
17. Gut Microbiota in Nonalcoholic Fatty Liver Diseases With and Without Type-2 Diabetes Mellitus, European Journal of Gastroenterology and Hepatology (2021)
18. Sarcopenia and Planning to Management: Review Article, Tehran University Medical Journal (2021)